DOI QR코드

DOI QR Code

Enhancement of anti-inflammatory and anti-tumorigenic properties of 3D-spheroid formed mesenchymal stem cells derived from rheumatoid arthritis joints

  • Seung-Chan, Lee (Apures, Inc., Central Research Center) ;
  • Chae-Yeon, Hong (College of Veterinary Medicine, Gyeongsang National University) ;
  • Yong-Ho, Choe (College of Veterinary Medicine, Gyeongsang National University) ;
  • Tae-Seok, Kim (College of Veterinary Medicine, Gyeongsang National University) ;
  • Won-Jae, Lee (College of Veterinary Medicine, Kyungpook National University) ;
  • Gyu-Jin, Rho (College of Veterinary Medicine, Gyeongsang National University) ;
  • Sung-Lim, Lee (College of Veterinary Medicine, Gyeongsang National University)
  • 투고 : 2022.11.26
  • 심사 : 2022.12.05
  • 발행 : 2022.12.31

초록

Current studies have revealed the capacity of mesenchymal stem cells (MSCs) in term of immunomodulatory properties, and this distinct potential is downgraded according to the disease duration of patients-derived MSCs. In order to enhance the immunomodulatory and anti-tumorigenic properties of the rheumatoid arthritis (RA) joints-derived MSCs, we aggregate synovial fluid-derived MSCs from RA joints (RA-hMSCs) into 3D-spheroids by the use of hanging drop culture method. Cells were isolated from synovial fluids of RA joints with longstanding active status over 13 years. For aggregation of RA-hMSCs into 3D-spheroids, cells were plated in hanging drops in 30 μL of advanced DMEM (ADMEM) containing 25,000-30,000 cells/drop and cultured for 48 h. To analyze the comparative immunomodulatory effects of 3D-spheroid and 2D monolayer cultured RA-hMSCs and then cells were cultured in ADMEM supplemented with 20% of synovial fluids of RA patients for 48 h and were evaluated by qRT-PCR for their expression of mRNA levels of inflammatory and anti-inflammatory markers. Cellular aggregation of RA-hMSCs was observed and cells were aggregate into a single sphere. Following treatment of RA patient's synovial fluids into the RA-hMSCs, spheroids formed RA-hMSCs showed significantly (p < 0.05) higher expression of TNFα stimulated gene/protein 6 (TSG-6) than the monolayer cultured RA-hMSCs. Therefore, the 3D-spheroid culture methods of RA-hMSCs were more effective than 2D monolayer cultures in suppressing inflammatory response treated with 20% of RA-synovial fluids by expression of TNFα (TSG-6) according to the immune response and enhanced secretion of inflammatory factors.

키워드

과제정보

This study was supported by a grant from the National Research Foundation (NRF) of Korea, funded by the government of the Republic of Korea (grant no. NRF-2021R1A2C1007054).

참고문헌

  1. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G. 2007. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum. 56:1175-1186. https://doi.org/10.1002/art.22511
  2. Bara JJ, Richards RG, Alini M, Stoddart MJ. 2014. Concise review: bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic. Stem Cells 32:1713-1723. https://doi.org/10.1002/stem.1649
  3. Bartosh TJ, Ylostalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, Lee RH, Choi H, Prockop DJ. 2010. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc. Natl. Acad. Sci. U. S. A. 107:13724-13729. https://doi.org/10.1073/pnas.1008117107
  4. Brott BK and Sokol SY. 2002. Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol. Cell. Biol. 22:6100-6110. https://doi.org/10.1128/MCB.22.17.6100-6110.2002
  5. Byun T, Karimi M, Marsh JL, Milovanovic T, Lin F, Holcombe RF. 2005. Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis. J. Clin. Pathol. 58:515-519. https://doi.org/10.1136/jcp.2004.018598
  6. Cheng NC, Wang S, Young TH. 2012. The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities. Biomaterials 33:1748-1758. https://doi.org/10.1016/j.biomaterials.2011.11.049
  7. Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noel D. 2005. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 52:1595-1603. https://doi.org/10.1002/art.21012
  8. Ge J, Guo L, Wang S, Zhang Y, Cai T, Zhao RC, Wu Y. 2014. The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev. Rep. 10:295-303. https://doi.org/10.1007/s12015-013-9492-x
  9. Guo L, Ge J, Zhou Y, Wang S, Zhao RC, Wu Y. 2014. Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intraarterial injection. Stem Cells Dev. 23:978-989. https://doi.org/10.1089/scd.2013.0338
  10. Hsu SH, Ni YH, Lee YC. 2013. Microwell chips for selection of bio-macromolecules that increase the differentiation capacities of mesenchymal stem cells. Macromol. Biosci. 13:1100-1109. https://doi.org/10.1002/mabi.201200472
  11. Huang SW, Tzeng SC, Chen JK, Sun JS, Lin FH. 2020. A dynamic hanging-drop system for mesenchymal stem cell culture. Int. J. Mol. Sci. 21:4298.
  12. Imura T, Nakagawa K, Kawahara Y, Yuge L. 2018. Stem cell culture in microgravity and its application in cell-based therapy. Stem Cells Dev. 27:1298-1302. https://doi.org/10.1089/scd.2017.0298
  13. Jaukovic A, Abadjieva D, Trivanovic D, Stoyanova E, Kostadinova M, Pashova S, Kestendjieva S, Kukolj T, Jeseta M, Kistanova E, Mourdjeva M. 2020. Specificity of 3D MSC spheroids microenvironment: impact on MSC behavior and properties. Stem Cell Rev. Rep. 16:853-875. https://doi.org/10.1007/s12015-020-10006-9
  14. Jones EA, Crawford A, English A, Henshaw K, Mundy J, Corscadden D, Chapman T, Emery P, Hatton P, McGonagle D. 2008. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum. 58:1731-1740. https://doi.org/10.1002/art.23485
  15. Lee HJ, Lee WJ, Hwang SC, Choe Y, Kim S, Bok E, Lee S, Kim SJ, Kim HO, Ock SA, Noh HS, Rho GJ, Lee SI, Lee SL. 2021. Chronic inflammation-induced senescence impairs immunomodulatory properties of synovial fluid mesenchymal stem cells in rheumatoid arthritis. Stem Cell Res. Ther. 12:502.
  16. Lee SI, Yeo SI, Kim BB, Ko Y, Park JB. 2016. Formation of size-controllable spheroids using gingiva-derived stem cells and concave microwells: morphology and viability tests. Biomed. Rep. 4:97-101. https://doi.org/10.3892/br.2015.539
  17. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C. 2001. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411:321-325. https://doi.org/10.1038/35077108
  18. Mason EF and Rathmell JC. 2011. Cell metabolism: an essential link between cell growth and apoptosis. Biochim. Biophys. Acta 1813:645-654. https://doi.org/10.1016/j.bbamcr.2010.08.011
  19. Mochizuki T, Muneta T, Sakaguchi Y, Nimura A, Yokoyama A, Koga H, Sekiya I. 2006. Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans. Arthritis Rheum. 54:843-853. https://doi.org/10.1002/art.21651
  20. Nauta AJ and Fibbe WE. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506. https://doi.org/10.1182/blood-2007-02-069716
  21. Petrie Aronin CE and Tuan RS. 2010. Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res. C Embryo Today 90:67-74. https://doi.org/10.1002/bdrc.20174
  22. Sekiya I, Ojima M, Suzuki S, Yamaga M, Horie M, Koga H, Tsuji K, Miyaguchi K, Ogishima S, Tanaka H, Muneta T. 2012. Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis. J. Orthop. Res. 30:943-949. https://doi.org/10.1002/jor.22029
  23. Talsania M and Scofield RH. 2017. Menopause and rheumatic disease. Rheum. Dis. Clin. North Am. 43:287-302. https://doi.org/10.1016/j.rdc.2016.12.011
  24. Tsai AC, Liu Y, Yuan X, Ma T. 2015. Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate. Tissue Eng. Part A 21:1705-1719. https://doi.org/10.1089/ten.TEA.2014.0314
  25. Wang CC, Chen CH, Hwang SM, Lin WW, Huang CH, Lee WY, Chang Y, Sung HW. 2009. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells 27:724-732. https://doi.org/10.1634/stemcells.2008-0944
  26. Zhao S, Wehner R, Bornhauser M, Wassmuth R, Bachmann M, Schmitz M. 2010. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev. 19:607-614. https://doi.org/10.1089/scd.2009.0345